Greene J N, Sandin R L, Villanueva L, Sinnott J T
Department of Internal Medicine, University of South Florida College of Medicine, Tampa 33612.
Ann Clin Lab Sci. 1993 May-Jun;23(3):203-6.
Haemophilus parainfluenzae is a frequent cause of "culture-negative" endocarditis (i.e., endocarditis owing to a fastidious organism which may require longer incubation periods and/or enrichment media for detection compared to traditional pathogens). More cases will probably be identified with improvements in growth and isolation techniques. A case of H. parainfluenzae endocarditis is presented in a patient with mitral valve prolapse, which illustrates the difficulty in diagnosing endocarditis when initial blood cultures are negative. Particularly, it emphasizes the difficulty in selecting appropriate antibiotic therapy since beta-lactamase producing organisms are being isolated with increased frequency. This report is unique in that it documents successful treatment with a cephalosporin and what is, to our knowledge, the third reported case of a beta-lactamase producing H. parainfluenzae causing endocarditis. The authors believe that beta-lactamase stable second or third generation cephalosporins should constitute initial treatment of H. parainfluenzae endocarditis until sensitivity studies become available, since beta-lactamase production by this organism would nullify the effect of the previous agent of choice, ampicillin.
副流感嗜血杆菌是“血培养阴性”心内膜炎的常见病因(即由苛养菌引起的心内膜炎,与传统病原体相比,可能需要更长的培养时间和/或增菌培养基才能检测到)。随着生长和分离技术的改进,可能会发现更多病例。本文报告了一例二尖瓣脱垂患者发生的副流感嗜血杆菌心内膜炎,该病例说明了初始血培养阴性时心内膜炎的诊断困难。特别是,它强调了选择合适抗生素治疗的困难,因为产β-内酰胺酶的菌株分离频率增加。本报告的独特之处在于,它记录了用头孢菌素成功治疗的病例,据我们所知,这是第三例产β-内酰胺酶的副流感嗜血杆菌引起心内膜炎的报告。作者认为,在获得药敏研究结果之前,β-内酰胺酶稳定的第二代或第三代头孢菌素应作为副流感嗜血杆菌心内膜炎的初始治疗药物,因为该菌产生的β-内酰胺酶会使先前的首选药物氨苄西林失效。